Skip to content

CME
NASH & Diabetes
- S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  - S3-E1.1 – Fatty Liver Prevalence May Be Higher Than Previously Thought, Especially Among Type 2 Diabetes Patients
  - S3-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance
NASH Tsunami
Events
- 2021 Events
Sponsorships
- Our Sponsors & Affiliates
- Sponsorship Programs
Surfers
Contact

Menu

CME
NASH & Diabetes
- S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  - S3-E1.1 – Fatty Liver Prevalence May Be Higher Than Previously Thought, Especially Among Type 2 Diabetes Patients
  - S3-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance
NASH Tsunami
Events
- 2021 Events
Sponsorships
- Our Sponsors & Affiliates
- Sponsorship Programs
Surfers
Contact

Day: January 2, 2022

All Podcast Categories

All Podcast Categories

NAFLD, Public Health

S2-E64.2 – Emerging NAFLD Public Health Agenda

Jeff Lazarus joins the Surfers to discuss the emerging NAFLD Public Health Agenda.

January 2, 2022

Discussion Group

Join The Discussion in our LinkedIn or Facebook Discussion Groups

Facebook Linkedin

Join The Live Recordings

Recording for this session will take place at 3:15p Eastern US time (1900H CET, 1800H BT) on Monday.

Register For Next Recording

Copyright © SurfingNASH.Com 2022

Linkedin Facebook Twitter Instagram

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Apple Spotify Youtube

Menu

CME
NASH & Diabetes
- S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  - S3-E1.1 – Fatty Liver Prevalence May Be Higher Than Previously Thought, Especially Among Type 2 Diabetes Patients
  - S3-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance
NASH Tsunami
Events
- 2021 Events
Sponsorships
- Our Sponsors & Affiliates
- Sponsorship Programs
Surfers
Contact

Join The Discussion…

Apple Spotify Youtube Soundcloud

NASH & Diabetes Podcast and NASH Tsunami Podcast

S3-E1.2 - NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance

S1-E1.2 – NAFLD Prevalence and Type 2 Diabetes in an Endocrinology Clinic: The Need for Screening and Vigilance

Fatty Liver Researcher and endocrinology key opinion leader Ken Cusi discusses the high levels of NAFLD prevalence and fibrosis among

August 18, 2022

S3-E41 – Improving NASH Clinical Trials By Reducing Screen Fail Rates

August 14, 2022

S3-E40.5 – From the Vault: Why Cirrhosis Matters In Clinical Trial Strategy

August 14, 2022

S3-E40.4 – Challenges of Alcohol Screening in Fatty Liver Disease

August 14, 2022

S3-E40.3 – Importance of Early Diagnosis in Lean NASH

August 12, 2022

S3-E40.2 – A Simple Diagnostic Algorithm for Lean NASH

August 12, 2022

S3-E40.1 – Best Practices in Lean NASH: How the Article Came About

August 10, 2022

S3-E40 – Best Practices in Lean NASH: Authors Provide Back Story

August 7, 2022

S3-E39.5 – From The Vault: Early, Accurate Patient Information Matters

August 7, 2022

S3-E39.4 – Patient Follow-Up Challenges in Modeling NASH Diagnostics

August 7, 2022

S3-E39.3 – NASH Challenges: Early Diagnosis & NASH Patient Management

Experience Nudge Learning!
Interested in a new way of learning?

Learn More About CME